SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 71 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2013. The put-call ratio across all filers is 5.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $838,000 | -96.4% | 7,361 | -46.6% | 0.00% | – |
| Q3 2018 | $23,423,000 | -13.0% | 13,778 | -10.9% | 0.00% | – |
| Q2 2018 | $26,916,000 | -71.2% | 15,469 | -69.7% | 0.00% | – |
| Q1 2018 | $93,562,000 | -26.3% | 51,127 | -10.2% | 0.00% | – |
| Q4 2017 | $126,970,000 | +60.3% | 56,937 | +108.5% | 0.00% | – |
| Q3 2017 | $79,190,000 | -38.2% | 27,307 | -5.1% | 0.00% | – |
| Q2 2017 | $128,053,000 | +603.9% | 28,776 | +637.1% | 0.00% | – |
| Q1 2017 | $18,193,000 | -50.1% | 3,904 | -34.7% | 0.00% | – |
| Q4 2016 | $36,436,000 | -56.1% | 5,983 | -60.3% | 0.00% | – |
| Q3 2016 | $83,025,000 | +208.2% | 15,068 | +112.5% | 0.00% | – |
| Q2 2016 | $26,942,000 | -78.2% | 7,090 | -67.4% | 0.00% | – |
| Q4 2015 | $123,402,000 | +12.6% | 21,764 | +5.2% | 0.00% | – |
| Q3 2015 | $109,641,000 | +58.7% | 20,687 | +148.6% | 0.00% | – |
| Q2 2015 | $69,081,000 | +334.8% | 8,323 | +142.0% | 0.00% | – |
| Q1 2015 | $15,888,000 | -8.7% | 3,439 | -45.1% | 0.00% | – |
| Q3 2014 | $17,406,000 | +1139.7% | 6,261 | +1714.8% | 0.00% | – |
| Q2 2014 | $1,404,000 | -45.1% | 345 | -39.5% | 0.00% | – |
| Q1 2014 | $2,559,000 | -69.0% | 570 | -61.1% | 0.00% | – |
| Q4 2013 | $8,242,000 | -92.0% | 1,464 | -93.5% | 0.00% | – |
| Q3 2013 | $102,729,000 | -21.8% | 22,479 | -26.0% | 0.00% | – |
| Q2 2013 | $131,298,000 | – | 30,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|